Voyager Therapeutics (VYGR) Construction in Progress (2016)
Voyager Therapeutics (VYGR) reported Construction in Progress of $3.0 million for Q4 2016.
Voyager Therapeutics (VYGR) Construction in Progress (2016) Analysis & Trends
Voyager Therapeutics (VYGR) has 1 years of Construction in Progress data on file, last reported at $3.0 million in Q4 2016.
- For the quarter ending Q4 2016, Construction in Progress changed N/A year-over-year to $3.0 million; the trailing twelve-month figure through Dec 2016 stood at $3.0 million (changed N/A YoY), and the FY2016 full-year result was $3.0 million, changed N/A from the prior year.
- Construction in Progress steadied at $3.0 million in Q4 2016.
- In the past five years, Construction in Progress ranged from a high of $3.0 million in Q4 2016 to a low of $3.0 million in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 137.45 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Voyager Therapeutics | 183.84 Mn | 42.36 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 3.00 Mn |